Imaizumi Takamichi, Nakagawa Hiroshi, Hori Ran, Watanabe Yasuo, Soga Shiro, Iida Kyoichiro, Onodera Hideyuki
Chemical Research Laboratories, R&D Division, Kyowa Hakko Kirin, Shizuoka, Japan.
Oncology Research Laboratories, R&D Division, Kyowa Hakko Kirin, Shizuoka, Japan.
J Antibiot (Tokyo). 2017 May;70(5):675-679. doi: 10.1038/ja.2016.166. Epub 2017 Jan 18.
GEX1A/herboxidiene (1) is a natural product isolated from Streptomyces sp. and has been reported to target the pre-mRNA splicing process. Although 1 was shown to have antitumor activity in vivo, weight loss was observed in mice when 1 was consecutively administered. We assumed that the carboxylic acid moiety was one of the causes of this toxicity. In this study, a series of amide, carbamate and urea analogues of 1 were synthesized and their antiproliferative activity was evaluated in vitro. The synthesis of urea analogues featured Curtius rearrangement following amine treatment with the one-pot procedure from 1. Furthermore, a structure-activity relationship study of the urea analogues revealed that the pharmacologically preferable basic side chains were acceptable and that compound 9g was equipotent to parent 1. These basic urea analogues would be promising leads for the development of novel antitumor agents.
GEX1A/赫波烯(1)是从链霉菌属中分离出的一种天然产物,据报道其作用于前体mRNA剪接过程。尽管1在体内显示出抗肿瘤活性,但连续给药时在小鼠中观察到体重减轻。我们推测羧酸部分是这种毒性的原因之一。在本研究中,合成了一系列1的酰胺、氨基甲酸酯和脲类似物,并在体外评估了它们的抗增殖活性。脲类似物的合成采用了从1开始经一锅法用胺处理后进行库尔提斯重排的方法。此外,对脲类似物的构效关系研究表明,药理学上合适的碱性侧链是可以接受的,并且化合物9g与母体1具有同等效力。这些碱性脲类似物有望成为开发新型抗肿瘤药物的先导化合物。